Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E, & Tillaboyev Sh.Sh. (2023). Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Eurasian Journal of Research, Development and Innovation, 26, 1–4. Retrieved from https://geniusjournals.org/index.php/ejrdi/article/view/5178